Mckesson (MCK) Operating Margin (2009 - 2026)
Mckesson (MCK) posted quarterly Operating Margin of 2.23% for Q1 2026, up 48.0% year-over-year from 1.51% in Q1 2025, and up 46.4% quarter-over-quarter from 1.53% in Q4 2025.
Mckesson (MCK) Operating Margin (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported Operating Margin for 18 consecutive years, with 2.23% the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Margin rose 48.0% year-over-year to 2.23%; the TTM figure through Mar 2026 stood at 1.54% (up 31.0% YoY), while the FY2026 annual figure was 1.54%, up 31.0% from the prior year.
- Operating Margin advanced to 2.23% in Q1 2026 per MCK's latest filing, from 1.53% in the prior quarter.
- Across five years, Operating Margin topped out at 2.23% in Q1 2026 and bottomed at 0.62% in Q3 2024.
- Historically, Operating Margin has averaged 1.38% across 5 years, with a median of 1.42% in 2023.
- Annual changes were most pronounced in 2022 — Operating Margin surged 133 bps — and 2023, when it sank 97 bps.
- Mckesson's Operating Margin stood at 1.76% in 2022, then sank by 55 bps to 0.79% in 2023, then jumped by 62 bps to 1.28% in 2024, then grew by 19 bps to 1.53% in 2025, then soared by 46 bps to 2.23% in 2026.
- Business Quant data shows MCK's Operating Margin at 2.23% in Q1 2026, 1.53% in Q4 2025, and 1.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.32% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -0.85% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -15.41% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25% |
| Mar 31, 2026 | 2.23% |
| Dec 31, 2025 | 1.53% |
| Sep 30, 2025 | 1.36% |
| Jun 30, 2025 | 1.06% |
| Mar 31, 2025 | 1.75% |
| Dec 31, 2024 | 1.28% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | 1.30% |
| Mar 31, 2024 | 1.59% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 1.23% |
| Jun 30, 2023 | 1.48% |
| Mar 31, 2023 | 1.42% |
| Dec 31, 2022 | 1.76% |
| Sep 30, 2022 | 1.60% |
| Jun 30, 2022 | 1.54% |
| Mar 31, 2022 | 0.96% |
| Dec 31, 2021 | 0.43% |
| Sep 30, 2021 | 0.81% |